Aptevo Therapeutics (APVO) Competitors

CNS Pharmaceuticals (NASDAQ:CNSP) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Do analysts rate CNSP or APVO?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CNS Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Aptevo Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has better earnings & valuation, CNSP or APVO?

Aptevo Therapeutics has higher revenue and earnings than CNS Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CNS Pharmaceuticals	N/A	N/A	-$18.85M	-$5.66	-0.04
Aptevo Therapeutics	$3.11M	0.10	-$17.41M	N/A	N/A

Which has more volatility & risk, CNSP or APVO?

CNS Pharmaceuticals has a beta of 2.67, suggesting that its share price is 167% more volatile than the S&P 500. Comparatively, Aptevo Therapeutics has a beta of 4.89, suggesting that its share price is 389% more volatile than the S&P 500.

Is CNSP or APVO more profitable?

CNS Pharmaceuticals' return on equity of -112.27% beat Aptevo Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CNS Pharmaceuticals	N/A	-603.40%	-421.35%
Aptevo Therapeutics	N/A	-112.27%	-64.39%

Does the media refer more to CNSP or APVO?

In the previous week, Aptevo Therapeutics had 1 more articles in the media than CNS Pharmaceuticals. MarketBeat recorded 2 mentions for Aptevo Therapeutics and 1 mentions for CNS Pharmaceuticals. Aptevo Therapeutics' average media sentiment score of 0.00 beat CNS Pharmaceuticals' score of -0.18 indicating that CNS Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CNS Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aptevo Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community favor CNSP or APVO?

Aptevo Therapeutics received 152 more outperform votes than CNS Pharmaceuticals when rated by MarketBeat users. However, 70.77% of users gave CNS Pharmaceuticals an outperform vote while only 52.66% of users gave Aptevo Therapeutics an outperform vote.

Company	Underperform	Outperform
CNS Pharmaceuticals	Outperform Votes 46 70.77%	Underperform Votes 19 29.23%
Aptevo Therapeutics	Outperform Votes 198 52.66%	Underperform Votes 178 47.34%

Do institutionals & insiders hold more shares of CNSP or APVO?

14.0% of CNS Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.1% of Aptevo Therapeutics shares are owned by institutional investors. 3.9% of CNS Pharmaceuticals shares are owned by insiders. Comparatively, 1.9% of Aptevo Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Aptevo Therapeutics beats CNS Pharmaceuticals on 8 of the 12 factors compared between the two stocks.